James Zou is a Stanford professor whose work applies AI to biology and medicine. Recent coverage includes Paper2Agent, which turns scientific manuscripts, including text, figures and data, into conversational AI agents; a virtual biotech made up of about 37,000 AI scientist agents for drug discovery, building on a 2025 virtual lab he led; and a HybridAgents paper on switching between latent-space reasoning and text interaction.
Together researchers propose Hybrid Reasoning AgentsA paper introduces HybridAgents, which switch between latent-space reasoning and text interaction via a lightweight HybridLink and keep hybrid context in continuous working memory, trained with HybridSFT and HybridRL. Across 3 model scales and 11 benchmarks it improves performance by 10.4% over frontier LLM agents while delivering 35.5%-54.7% token savings; code is open-sourced.
Virtual biotech uses AI agents for drug discoveryA Stanford Medicine spinout created a virtual biotech company composed of about 37,000 AI scientist agents covering the drug development pipeline, reportedly predicting trial success and independently designing a lung cancer therapy later validated in trials. The effort builds on a 2025 virtual lab led by James Zou and Harrison Zhang.
Paper2Agent turns papers into conversational AI agentsA Stanford Medicine team released Paper2Agent, which converts scientific manuscripts (text, figures, data) into AI agents that can answer questions and interact with other paper agents; the work was published in Nature and authored by Jiacheng Miao and James Zou.
The A.I. Daily